Cerevance Beta, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Early Parkinson's Disease Monotherapy With CVN424 (NCT06006247) | Cerevance Beta, Inc. | 2023-09-11 |
| Relative Bioavailability and Food Effect Study of CVN424 (NCT05635461) | Cerevance Beta, Inc. | 2022-10-09 |
| Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations (NCT04191577) | Cerevance Beta, Inc. | 2019-12-02 |
| Study of CVN424 in Healthy Subjects (NCT03657030) | Cerevance Beta, Inc. | 2018-09-18 |
Track Cerevance Beta, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.